By Catherine Eckford (European Pharmaceutical Review)2024-03-04T17:06:18
Novartis has revealed new data for its one-time gene therapy for spinal muscular atrophy (SMA) in older children.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-04-14T12:32:00Z
Sponsored by Thermo Fisher Scientific
2026-04-14T12:29:00Z
Sponsored by JRS Pharma, In association with Vetter Pharma
2026-03-27T15:37:00
Sponsored by IMA Pharma
2025-09-17T08:00:00
Sponsored by Mastercontrol
2026-02-25T15:00:00
Sponsored by Particle Measuring Systems
2026-05-27T13:00:00 2026-05-27T14:00:00
Sponsored by TA Instruments
2025-07-10T12:58:00
Sponsored by FUJIFILM Wako Pure Chemical Corporation
Site powered by Webvision Cloud